Balyasny Asset Management L.P.

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1218710 Chicago, IL

Position in ALLO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,886,071

+$2,761,132 QoQ

Shares Held

1,182,816

+2105.8% QoQ

Ownership

0.343%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $2,162,876,033 across 177 Biotechnology names. ALLO ranks #107 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	2,779,445	$146,532,340
2	ERAS	Erasca, Inc.	5,143,985	$83,229,677
3	TNGX	Tango Therapeutics, Inc.	3,826,659	$80,053,706
4	APLS	Apellis Pharmaceuticals, Inc.	1,917,501	$77,141,065
5	BMRN	Biomarin Pharmaceutical Inc	1,362,752	$76,981,860
6	CYTK	Cytokinetics Inc	992,545	$65,418,640
7	DAWN	Day One Biopharmaceuticals, Inc.	2,625,235	$56,285,038
8	FOLD	AMICUS THERAPEUTICS, INC.	3,827,513	$55,345,837

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,886,071	1,182,816	+2105.8%	Shares	Sole	2026-05-15
2024-06-30	$124,939	53,622	+151.5%	Shares	Sole	2024-08-14
2024-03-31	$95,286	21,317	+35.5%	Shares	Sole	2024-05-13
2023-12-31	$50,493	15,730	-90.7%	Shares	Sole	2024-02-14
2022-12-31	$1,059,160	168,388	+306.0%	Shares	Other	2023-02-14
2022-09-30	$447,972	41,479	-57.8%	Shares	Other	2022-11-15
2021-03-31	$3,466,742	98,208	-33.2%	Shares	Sole	2021-05-17
2020-09-30	$5,545,594	147,059	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.